Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Eli Lilly

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Armed with hashtags, these activists made insulin prices a presidential talking point

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who’d hacked their insulin pumps to automatically adjust the amount of insulin delivered.

Tribune News Service

Ignore the ‘superpower’ boasts – UK pharma looks superchallenged

NHS crisis, withdrawal of tax credits and exit from EU blamed for fall in UK share of R&D market

The Guardian - UK

Lilly shares slip as FDA seeks more Alzheimer's drug data

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

The Independent UK

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Salon

Read news from The Economist, FT, and more,
with one subscription

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

Axios

Tesla share plunge puts market cap behind LVMH, Nvidia, Eli Lilly

Tesla shares fell 12.2% on Tuesday after missing expectations on fourth-quarter deliveries.

Fortune

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

Twitter to re-launch blue tick subscription service after first chaotic rollout backfired

The platform’s Blue subscriptions will return with $8 monthly charges, or $11 a month for iPhone users

The Independent UK

Top executives explain how they achieve ESG goals amid backlash

How should companies reframe ESG initiatives amid controversy? These executives offer their strategies.

Fortune

Twitter has lost 50 of its top 100 advertisers since Elon Musk took over, report says

Half of Twitter's top 100 advertisers appear to no longer be advertising on the website. A new report states that these 50 advertisers have spent almost $2 billion on Twitter ads since 2020.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Elon Musk's Twitter Blue fiasco: Governments need to better regulate how companies use trademarks

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

The Guardian - US

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

The Conversation

Impersonation and parody: Shitposters satirically mock Elon Musk’s chaotic Twitter takeover

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

France 24

Profit, privacy and online safety: What's at stake with Twitter verification

The past week has seen Twitter announce – and quickly retract – new rules for authenticating user profiles, notably a controversial proposal to offer “blue check” verification to anyone willing to pay $8 a month. New owner Elon Musk, who on Tuesday set November 29 as the scheme’s relaunch date,…

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Balenciaga becomes the first major brand to delete its Twitter account

Fashion house Balenciaga has become the first brand to delete its Twitter account since the Musk acquisition.

Asharq Al-Awsat

Twitter Prank Spurs Unexpected Scrutiny of Insulin Prices

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

Benzinga

These Stocks Are Still Feeling The Heat From Elon Musk's Twitter Blue Dumpster Fire

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk kicked off his first week at the helm of Twitter with a bang — but it backfired.<

Daily Mirror

Elon Musk fans spend £500,000 on GOAT monument in honour of controversial Twitter owner

The world's richest man will be presented with the statue at his Tesla HQ in Austin, Texas, next month

Fortune

Musk says Twitter Blue will ‘probably’ return by the ‘end of next week’ after trolling of companies, celebs by imposters

Pranked companies like Eli Lilly and Lockheed Martin will no doubt be watching closely.

ABC News

Pharmaceutical giant Eli Lilly & Co apologises after fake Twitter account says insulin is free as Elon Musk rolls back verification

The incident is among a wave of impersonations that prompted Twitter to make its relaunched premium service unavailable.

Fortune

No, insulin is not free: Eli Lilly is the latest high-profile casualty of Elon Musk’s Twitter verification mess

Eli Lilly shares fell after pranksters using Twitter Blue impersonated it and made a surprising claim—and this might be just the beginning.

1 … 27 28 29 30

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.